PMA device
TRIFORMIS RESILIA Tricuspid Valve
Edwards Lifesciences, LLC · Heart-Valve, Non-Allograft Tissue (LWR, Class III) · First FDA decision Oct 27, 2025, newest May 26, 2026Aortic stenosisMitral regurgitationTricuspid regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
1
Naming "TRIFORMIS RESILIA"
MAUDE reports
0
Brand "TRIFORMIS RESILIA", since 2015
PubMed studies
0
Mentioning "TRIFORMIS RESILIA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TRIFORMIS RESILIA Tricuspid Valve
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- TRIFORMIS RESILIA Tricuspid Valve, Model 11300T Available in sizes: 25, 27, 29, 31 and 33 mmPMA supplement
P150048-S094 · Decided May 26, 2026 · 189 days after receipt · Normal 180 Day Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- TRIFORMIS RESILIA Tricuspid Valve, Model 11300TPMA supplement
P150048-S097 · Decided Feb 6, 2026 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- TRIFORMIS RESILIA Tricuspid Valve, Model 11300TPMA supplement
P150048-S096 · Decided Feb 6, 2026 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TRIFORMIS RESILIA", any status and sponsor, newest update first.
Edwards LifesciencesPublic (EW)
NCT07684313 · 75 participants (planned) · Start Sep 22, 2026 · Primary completion Aug 2030
Device: Edwards TRIFORMIS RESILIA heart valve · For: Heart Valve Diseases; Heart Diseases; Cardiovascular Diseases and 1 more
Sites: Carmel, Indiana
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TRIFORMIS RESILIA", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LWR
17,256 reports: 871 malfunction, 15,439 injury, 934 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TRIFORMIS RESILIA"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LWR.
- Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2022
- St. Jude Medical Biocor and Biocor Supra ValvesAbbott Medical · PMA 2012
- INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2026
- Mitroflow Aortic Pericardial Heart ValveCorcym Canada Corp · PMA 2019
- Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart ValveCorcym S.r.l. · PMA 2025
- Sjm Biocor Valve / Sjm Biocor Supra ValveAbbott Medical · PMA 2016
- Ats 3F Aortic Bioprosthesis Model 1000Medtronic, Inc. · PMA 2019
- Freestyle Aortic Root BioprosthesisMedtronic, Inc. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.